Revolinski, SL, Munoz-Price, LS.
Clostridium difficile in immunocompromised hosts: a review of epidemiology, risk factors, treatment, and prevention. Clin Infect Dis 2019;68:2144–2153.
Janarthanan, S, Ditah, I, Adler, DG, Ehrinpreis, MN.
Clostridium difficile–associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol 2012;107:1001–1010.
Dial, S, Delaney, JA, Barkun, AN, Suissa, S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005;294:2989–2995.
Ziegler, M, Landsburg, D, Pegues, D, et al. Clinical characteristics and outcomes of hematologic malignancy patients with positive Clostridium difficile toxin immunoassay versus polymerase chain reaction test results. Infect Control Hosp Epidemiol 2018;39:863–866.
Wahking, RA, Steele, RL, Hanners, RE, Lockwood, SM, Davis, KW. Outcomes from a pharmacist-led proton pump inhibitor stewardship program at a single institution. Hosp Pharm 2018;53:59–67.
Kandel, CE, Gill, S, McCready, J, Matelski, J, Powis, JE. Reducing coadministration of proton pump inhibitors and antibiotics using a computerized order entry alert and prospective audit and feedback. BMC Infect Dis 2016;16:355.
Kwok, CS, Arthur, AK, Anibueze, CI, Singh, S, Cavallazzi, R, Loke, YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 2012;107:1011–1019.
MacLaren, R, Reynolds, PM, Allen, RR. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med 2014;174:564–574.
Sartori, S, Trevisani, L, Nielsen, I, Tassinari, D, Panzini, I, Abbasciano, V. Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury. J Clin Oncol 2000;18:463–467.
Numico, G, Fusco, V, Franco, P, Roila, F. Proton pump inhibitors in cancer patients: how useful they are? A review of the most common indications for their use. Crit Rev Oncol Hematol 2017;111:144–151.